Dysbiosis clinical trials

Explore recruiting dysbiosis clinical trials.

Recruiting dysbiosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dysbiosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

FMT-SPA - RANDOMIZED DOUBLE BLIND CONTROLLED STUDY ASSESSING THE EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RESISTANT TO CONVENTIONAL TREATMENT

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Stopping anti-TNF treatment in Crohn's and Colitis patients in remission

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

A combined treatment with GM-CSF, fosfomycin and metronidazole for pouchitis in ulcerative colitis patients after restorative ileal pouch anal anastomosis surgery. A clinical safety and proof-of-concept study

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

AUTOP 2 : Screen-and-treat strategy for vaginal flora abnormalities by molecular biology in pregnant women at high risk of preterm birth: A Multicentre, Randomized Study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematopoietic cell transplantation complications

Germany, France, Belgium, Spain, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Dysbiosis trials by city

Dysbiosis in Toronto Dysbiosis in Vancouver Dysbiosis in Montreal Dysbiosis in Calgary Dysbiosis in Edmonton Dysbiosis in Ottawa Dysbiosis in Winnipeg Dysbiosis in Quebec City Dysbiosis in Hamilton Dysbiosis in Kitchener Dysbiosis in London Dysbiosis in Halifax Dysbiosis in New York Dysbiosis in Los Angeles Dysbiosis in Chicago Dysbiosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease